Biomedical papers - Ahead of Print

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. X:X | 10.5507/bp.2017.007

Vaginal use of micronized progesterone for luteal support.A randomized study comparing Utrogestan® and Crinone® 8%

Lucie Michnovaa, Jiri Dostalb, Milan Kudelab,c, Petr Hamald, Katerina Langovae
a IVF Clinic Olomouc, Horni Lan 6, Olomouc, Czech Republic
b Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, Palacky University, Olomou, Czech Republic
c Department of Health Care Sciences, Faculty of Humanities, Thomas Bata University in Zlin, Czech Republic
d Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
e Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic

Background and Objective. Luteal phase physiology is distorted by in vitro fertilization (IVF) cycles using gonadotropin-releasing hormone (GnRH) agonists and antagonists, Controlled ovarian hyperstimulation leads to luteal phase defect and for this reason, luteal phase support is now an integral part of IVF/ICSI-ET programs. The support is provided by hCG, progesterone or GnRH-a. This study compared the efficiency, safety and tolerance of two vaginal micronized progesterones, Utrogestan and Crinone 8%.

Methods: 111 women, 18-40 years old, FSH < 10 IU/L and normal uterus findings were included. The efficiency of the two preparations to provide luteal support was evaluated by the fertilization, implantation, pregnancy and take-home baby rates. The safety was compared through the results of vaginal findings and vaginal inflammation markers before and after treatment. Comparison of tolerance was made by evaluating 21 subjective patient questionnaire parameters.

Results: There were no significant differences between the preparations in terms of efficiency or safety though Crinone 8% was better tolerated.

Conclusion: The outcomes of this study suggest that a vaginal gel with micronized progesterone (Crinone 8%) is the optimal choice at this time for luteal support.

Keywords: luteal phase support, IVF/ET, Progesterone, Utrogestan, Crinone 8%

Received: November 4, 2016; Accepted: February 24, 2017; Prepublished online: March 14, 2017


References

  1. Data mentioned here relate to situation from 29th June 2015, www.uzis.cz
  2. International data come from the European Registry of Assisted Reproduction EIM, which operates under supervision of European Society of Human Reproduction and Embryology -ESHRE, ESHRE, 2014 b. ART fact sheet. ESHRE. European Society of Human Reproduction and Embryology [online]. 2014 [cit. 2015-07-01]. Available from: http://www.eshre.eu/Guidelines-and-Legal/ART-fact-sheet.aspx
  3. Devoto L, Vega M, Kohen P. Endocrine and paracrine-autocrine regulation of the human corpus luteum during the mid-luteal phase. J Reprod Fertil 2000;55(Suppl):13-20.
  4. Toner JP. The luteal phase: luteal support protocols. In Gardner DK, Weissman A, Howles CM, eds. Textbook of assisted reproductive techniques. 2nd ed. London: Tailor & Francis; 2004. p. 639-650.
  5. Lejeune B, Camus M, Deschacht J, Leroy F. Differences in the luteal phases after failed or successful in vitro fertilization and embryo replacement. J In Vitro Fert Embryo Transf 1986; 3(6):358-65. Go to original source... Go to PubMed...
  6. Harper MJ. The implantation window. Baillieres Clin Obstet Gynaecol 1992;6(2):351-71. Go to original source... Go to PubMed...
  7. Minas V, Loutradis D, Makrigiannakis A. Factors controlling blastocyst implantation. Reprod Biomed Online 2005;10(2):205-16. Go to original source... Go to PubMed...
  8. Penzias AS. Luteal phase support. Fertil Steril 2002;77(2):318-23. Go to original source... Go to PubMed...
  9. Scott R, Navot D, Liu HC, Rosenwaks Z. A human in vivo model for the luteoplacental shift. Fertil Steril 1991;56(3):481-4. Go to original source... Go to PubMed...
  10. Csapo AI, Pulkkinen MO, Ruttner B. The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies. Am J Obstet Gynecol 1972;112(8):1061-7. Go to original source... Go to PubMed...
  11. Van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles (Review). The Cochrane Library 2011, Issue 10.
  12. Hohmann FP, Laven JS, de Jong FH. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. Hum Reprod 2001;16(5):846-54. Go to original source... Go to PubMed...
  13. Fauser BC, Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab 2003;14(5):236-42. Go to original source... Go to PubMed...
  14. Beckers NG, Platteau P, Eijkemans MJ. The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. Eur J Endocrinol 2006;155(2):355-63. Go to original source... Go to PubMed...
  15. Hild-Petito S, Fazleabas AT. Expression of steroid receptors and steroidogenic enzymes in the baboon (Papio anubis) corpus luteum during the menstrual cycle and early pregnancy. J Clin Endocrinol Metab 1997;82(3):955-62. Go to PubMed...
  16. Edwards RG, Steptoe PC, Purdy JM. Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 1980;87(9):737-56. Go to original source... Go to PubMed...
  17. Jones HW Jr, Jones GS, Hodgen GD, Rosenwaks Z, eds. IVF-Norfolk. 1st ed. Baltimore: Williams & Wilkins; 1986.
  18. Beckers NG, Macklon NS, Eijkemans MJ. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 2003;88(9):4186-92. Go to original source... Go to PubMed...
  19. Beckers NG, Laven JS, Eijkemans MJ, Fauser BC. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization. Hum Reprod 2000;15(1):43-9. Go to original source... Go to PubMed...
  20. Bourgain C, Devroey P, Van Waesberghe L. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod 1990;5(5):537-43. Go to original source... Go to PubMed...
  21. Fatemi HM, Popovic-Todorovic B, Papanikolaou E. An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update 2007;13(6):581-90. Go to original source... Go to PubMed...
  22. Chakravarty BN, Shirazee HH, Dam P. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study. J Steroid Biochem Mol Biol 2005;97(5):416-20. Go to original source... Go to PubMed...
  23. Levine H. Luteal support in IVF using the novel vaginal progesterone gel Crinone 8%: results of an open-label trial in 1184 women from 16 US centers. Fertil Steril 2000;74(4):836-7. Go to original source... Go to PubMed...
  24. Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 2002;17(9):2287-99. Go to original source... Go to PubMed...
  25. Propst AM, Hill JA, Ginsburg ES. A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertil Steril 2001;76(6):1144-9. Go to original source... Go to PubMed...
  26. Bouckaert Y, Robert F, Englert Y. Acute eosinophilic pneumonia associated with intramuscular administration of progesterone as luteal phase support after IVF: case report. Hum Reprod 2004;19(8):1806-10. Go to original source... Go to PubMed...
  27. de Ziegler D, Seidler L, Schärer E. Non-oral administration of progesterone: experiences and possibilities of the transvaginal route. Praxis 1995;84(5):127-33. Go to PubMed...
  28. Cicinelli E, de Ziegler D, Bulletti C. Direct transport of progesterone from vagina to uterus. Obstet Gynecol 2000; 95(3):403-6. Go to PubMed...
  29. Ludwig M, Schwartz P, Babahan B. Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study. Eur J Obstet Gynecol Reprod Biol 2002;103(1):48-52. Go to original source... Go to PubMed...
  30. Simunic V, Tomic V, Tomic J, Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. Fertil Steril 2007;87(1):83-7. Go to original source... Go to PubMed...
  31. Araujo E Jr., Bernardini L, Frederick JL. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction. J Assist Reprod Genet 1994;11(2):74-8. Go to original source... Go to PubMed...
  32. Tesarik J, Hazout A, Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Human Reproduction 2004;19(5):1176-80. Go to original source... Go to PubMed...
  33. Farhi J, Weissman A, Steinfeld Z. Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 2000;73(4):761-6. Go to original source... Go to PubMed...
  34. Kolibianakis EM, Venetis CA, Papanikolaou EG. Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and meta-analysis. Hum Reprod 2008;23(6):1346-54. Go to original source... Go to PubMed...
  35. Nyboe Andersen A, Popovic-Todorovic B, Schmidt KT. Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Hum Reprod 2002;17(2):357-61. Go to original source... Go to PubMed...
  36. Proctor A, Hurst BS, Marshburn PB. Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization. Fertil Steril 2006;85(5):1550-2. Go to original source... Go to PubMed...